Efficacy and Safety of Nusinersen in Children With Later-Onset Spinal Muscular Atrophy (SMA): End of Study Results From the Phase 3 CHERISH Study
View entire presentationCategories
Finance PresentationsTechnology PresentationsBanking PresentationsInformation Technology PresentationsOil and Energy PresentationsInternet PresentationsMining and Metals PresentationsCommunications PresentationsReal Estate PresentationsBiotechnology PresentationsAutomotive PresentationsMedical PresentationsRetail PresentationsEnergy Presentations